Core Viewpoint - Morgan Stanley expresses optimism for the Chinese capital market in 2026, expecting continued growth in the MSCI China Index and the CSI 300 Index, with target levels set at 100 points and 5200 points respectively by the end of 2026, indicating potential increases of 19% and 17% from November 24 [1] Group 1: Investment Themes - The acceleration of "anti-involution" policies is expected to structurally enhance profit margins and return on equity (ROE) for the MSCI China Index and CSI 300 Index, with current market estimates for net profit margins and ROE being relatively low [1] - Strong growth in global artificial intelligence infrastructure capital expenditure is anticipated to boost China's local AI ecosystem and related domestic industries, with emerging "world dynamic models" increasing demand for computing power [1] - The fiscal and monetary easing environment in developed markets is likely to stabilize China's export sales [1] - Consumption is showing a K-shaped recovery, with significant growth in high-end food and beverage and luxury goods sales, while mid-tier consumption recovery remains relatively weak [1] Group 2: Preferred Stocks - Morgan Stanley lists its preferred Chinese stocks for the first quarter of next year, including Baidu, NetEase, Midea Group, Mixue Group, Pinduoduo, Pop Mart, Trip.com, Master Kong, Futu Holdings, Sinopharm, CATL, and China Overseas Development [1] - Additionally, the bank identifies preferred stocks benefiting from the AI supercycle, including cloud service providers (CSP) like Alibaba and Tencent, AI data center companies (AIDC) such as Zhongji Xuchuang, Huqin Technology, and Northern Huachuang, as well as electrification and battery material firms like CATL, Yiwei Lithium Energy, and Ganfeng Lithium [2]
小摩:预期2026年底沪深300指数目标5200点,列出中资股首选股名单